Literature DB >> 1985296

Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease.

J P Kesslak1, O Nalcioglu, C W Cotman.   

Abstract

The brains of patients with Alzheimer's disease (AD) invariably exhibit neuropathology in the hippocampus and entorhinal cortex when examined postmortem. Magnetic resonance imaging (MRI) offers a noninvasive, high-resolution method for quantifying volumetric changes in the AD brain antemortem. Eight patients diagnosed with probable AD and 7 age-matched controls had MRI scans and were tested on a battery of cognitive and olfactory tests. The hippocampus and entorhinal cortex (parahippocampal gyrus) showed significant atrophy, with over 40% reduction in size. Areas of the brain that are not highly involved in the degenerative state of AD, such as the striatum, did not show significant volumetric changes. Hippocampal and parahippocampal gyrus volumes had the highest correlation with scores on the Mini-Mental State Examination (r = 0.89), with lower correlations for a smell identification test (r = 0.65), odor match-to-sample test (r = 0.72), and a visual match-to-sample test (r = 0.26).

Entities:  

Mesh:

Year:  1991        PMID: 1985296     DOI: 10.1212/wnl.41.1.51

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  81 in total

1.  Magnetization transfer measurements of the hippocampus in patients with Alzheimer's disease, vascular dementia, and other types of dementia.

Authors:  H Hanyu; T Asano; T Iwamoto; M Takasaki; H Shindo; K Abe
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

2.  An MRI-based semiquantitative index for the evaluation of brain atrophy and lesions in Alzheimer's disease, mild cognitive impairment and normal aging.

Authors:  Wei Chen; Xiaowei Song; Yunting Zhang; Sultan Darvesh; Ningnannan Zhang; Ryan C N D'Arcy; Sandra Black; Kenneth Rockwood
Journal:  Dement Geriatr Cogn Disord       Date:  2010-08-21       Impact factor: 2.959

3.  Disruption of odour quality coding in piriform cortex mediates olfactory deficits in Alzheimer's disease.

Authors:  Wen Li; James D Howard; Jay A Gottfried
Journal:  Brain       Date:  2010-08-19       Impact factor: 13.501

4.  Comparison of gray matter and metabolic reduction in mild Alzheimer's disease using FDG-PET and voxel-based morphometric MR studies.

Authors:  Kazunari Ishii; Hiroki Sasaki; Atsushi K Kono; Naokazu Miyamoto; Tetsuya Fukuda; Etsuro Mori
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-31       Impact factor: 9.236

5.  The relationship between cerebral Alzheimer's disease pathology and odour identification in old age.

Authors:  R S Wilson; S E Arnold; J A Schneider; Y Tang; D A Bennett
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-09-29       Impact factor: 10.154

6.  Translation of imaging biomarkers from clinical research to healthcare.

Authors:  Ingo Kilimann; Jochen René Thyrian; Wolfgang Hoffmann; Stefan J Teipel
Journal:  Z Gerontol Geriatr       Date:  2017-04-12       Impact factor: 1.281

Review 7.  Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.

Authors:  Lisa Mosconi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-04       Impact factor: 9.236

8.  Major decrease in the volume of the entorhinal cortex in patients with Alzheimer's disease carrying the apolipoprotein E epsilon4 allele.

Authors:  K Juottonen; M Lehtovirta; S Helisalmi; P J Riekkinen; H Soininen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-09       Impact factor: 10.154

9.  Bayesian adaptive group lasso with semiparametric hidden Markov models.

Authors:  Kai Kang; Xinyuan Song; X Joan Hu; Hongtu Zhu
Journal:  Stat Med       Date:  2018-11-28       Impact factor: 2.373

10.  MRI-based quantitative assessment of the hippocampal region in very mild to moderate Alzheimer's disease.

Authors:  M Ikeda; H Tanabe; Y Nakagawa; H Kazui; H Oi; H Yamazaki; K Harada; T Nishimura
Journal:  Neuroradiology       Date:  1994       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.